Quick Search

 

 


 

 

Home > Result Summaries: Compounds > casopitant > Result Summary for NKV105097

Result Summary for NKV105097

Result Summary
Protocol ID: NKV105097
Clinical Study ID: NKV105097
Official Title: An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin when Co-administered with Repeat Doses of Casopitant [GW679769] in Healthy Adult Subjects.
Phase: phase 1
Study Indications or Diseases:
  • Nausea and Vomiting, Chemotherapy-Induced
Generic Name: casopitant
Trade/Product Name: Rezonic,Zunrisa
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Kirby LC; Johnson BM; Adamns LM; Eberwein DJ; Zhang K; Murray SC; Lates CD; Blum RA; Morris SR. Effect of Casopitant, a Novel NK-1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin. J Clin Pharmacol 2010 May; 50(5):566-575

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.